Regeneron Pharmaceuticals, Inc. (BVMF:REGN34)
66.00
-1.28 (-1.90%)
At close: Dec 2, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 398.93 billion as of December 5, 2025. Its market cap has decreased by -13.65% in one year.
Market Cap
398.93B
Enterprise Value
312.20B
Revenue
75.93B
Ranking
n/a
PE Ratio
16.35
Stock Price
66.00
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 177.17M to 398.93B, an increase of 225,071.02%. That is a compound annual growth rate of 26.00%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.09B |
| Raia Drogasil | 41.21B |
| Hypera | 16.96B |
| Fleury | 8.28B |
| Odontoprev | 6.42B |
| Diagnósticos da América | 4.37B |
| Empreendimentos Pague Menos | 4.01B |
| Blau Farmacêutica | 2.38B |